Mesalazine/Nifedipine

美沙拉嗪/硝苯地平

Report date: 2022/05/26 15:48:09

Base Information

Drug NameMesalazine/Nifedipine
Drug Alias Name美沙拉嗪+硝苯地平Mesalazine+Nifedipine硝苯地平+美沙拉嗪Nifedipine/Mesalazine硝苯地平/美沙拉嗪 +[7] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersProtein phosphatase 2A inhibitors
TargetsVoltage-gated calcium channelProtein phosphatase 2A
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes MesalazineNifedipine
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBracco International Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBracco Spa
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A